15 Days Price Change
Summary
🚨 NSE vs BSE: Valuation Mirage\r\nDespite dominating India\'s capital markets with 9x profits and 95% share, NSE trades at a discount to BSE. With its IPO around the corner, is the market finally ready to correct this mispricing? Here\'s why NSE might be the true underdog — for now.
The buzz around the NSE IPO has ignited a key debate among investors: Is NSE (National Stock Exchange) truly undervalued, or is BSE riding the hype wave? A closer look at the numbers makes it clear — NSE's IPO could correct a long-standing valuation mismatch in India’s stock exchange space.
FY25 Snapshot:
Revenue: NSE ₹17,141 Cr | BSE ₹2,957 Cr
EBITDA: NSE ₹14,811 Cr | BSE ₹1,779 Cr
PAT: NSE ₹12,188 Cr | BSE ₹1,322 Cr
That’s a 5x to 9x outperformance across all major financial metrics.
NSE: 71% PAT margin, 86% EBITDA margin, ROE 40%, ROCE 50%
BSE: ~45% PAT margin, ~60% EBITDA margin, ROE 34%, ROCE 44%
Verdict: NSE is far more profitable, efficient, and capital-generative.
Market Share (FY25):
Cash Market: NSE ~95% | BSE ~5%
Equity Futures: NSE ~100%
Equity Options: NSE ~88% | BSE ~12%
Currency Derivatives: NSE ~93% | BSE ~7%
NSE isn’t just India’s leading exchange — it’s a global giant, ranked #1 in derivatives volume and #2 in equity trades worldwide.
Metric |
NSE (Unlisted) |
BSE (Listed) |
Market Cap |
₹5.92 Lakh Cr |
₹1.21 Lakh Cr |
P/E Ratio |
~49x |
~92x |
EV/EBITDA |
~39x |
~61x |
PEG Ratio |
~0.97 |
~0.80 |
Despite its superior earnings, scale, and margins, NSE is trading at lower multiples than BSE. That’s a textbook example of valuation disconnect.
Why is BSE trading at such high multiples? Here’s the likely loop:
NSE is unlisted, so retail investors buy BSE as a proxy bet.
Increased demand pushes BSE’s P/E higher.
That feeds sentiment around NSE’s perceived value.
The cycle continues — until the NSE IPO introduces price discovery.
NSE’s Growth Drivers:
BSE’s Growth Levers:
Mutual fund distribution
SME segment listings
Income from investments
FY25 PAT Growth:
NSE: +47% | BSE: +71%
3-Year CAGR:
NSE: ~32–33% | BSE: ~74–76%
While BSE’s growth rates are temporarily higher, NSE’s businesses are higher-margin, recurring, and defensible. That’s key when judging long-term value.
The upcoming NSE IPO is likely to be a market-defining event.
Here’s what it will trigger:
A benchmark valuation for Indian exchanges.
Capital rotation as funds move from BSE to NSE.
Clarity for investors, correcting the proxy-driven distortion in exchange stock prices.
Don’t just look at market cap. Dive into margins, scale, and ROE/ROCE.
NSE is a business of moats. Its dominance in derivatives and index-linked services ensures longevity.
Watch for listing-day signals. NSE’s IPO pricing will reset how we value BSE too.
Understand revenue quality. Recurring, sticky income wins in the long term.
BSE is not a bad stock — it’s just not NSE. One is a challenger. The other is the incumbent giant.
NSE’s final IPO pricing and grey market trends
Mutual fund & SME performance updates from BSE
Regulatory developments in capital markets
Growth in derivative volumes and retail participation
The numbers don’t lie — NSE is bigger, more profitable, more dominant, yet still undervalued compared to BSE. Its IPO may finally give investors a chance to buy into India’s true market infrastructure titan — at a price that reflects its real power.
The NSE IPO isn’t just a listing. It’s a reset.
📢 Stay tuned with Sharescart for exclusive unlisted stock insights, IPO coverage, and deep-dive investment analysis.
Sell or Purchase Share (Tentative Price)
Company | Industry | Stock P/E | P/B | Company rating | MCAP (in Cr.) | Current Price |
---|---|---|---|---|---|---|
Pharmeasy | e-Commerce | -2.2 | 2.1 | 5463 | 8.5 | |
Reliance Retail | Retailing | 141.5 | 23 | 698659 | 1400 | |
Orbis Financial | Finance - Investment | 47.8 | 9.8 | 6756 | 555 |
How Your Money Can Grow With Us